Similar Papers

Paper Title
Journal
Date
Author
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non–Small Cell Lung Cancer: A Predictive Marker of Efficacy?
Jordi Remon ... Benjamin Besse
Journal of Thoracic Oncology | VOL. 14
Jordi Remon, et. al.Jordi Remon ... Benjamin Besse
23 Apr 2019
Repeated dynamic [18F]FDG PET/CT imaging using a high-sensitivity PET/CT scanner for assessing non-small cell lung cancer patients undergoing induction immuno-chemotherapy followed by hypo-fractionated chemoradiotherapy and consolidative immunotherapy: report from a prospective observational study (GASTO-1067).
Daquan Wang ... Jinyu Guo
European journal of nuclear medicine and molecular imaging | VOL. 51
Daquan Wang, et. al.Daquan Wang ... Jinyu Guo
02 Jul 2024
Induction Immunochemotherapy Followed by Definitive Chemoradiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer
L Wu ... Y Xu
International Journal of Radiation Oncology*Biology*Physics | VOL. 117
L Wu, et. al.L Wu ... Y Xu
29 Sep 2023
Impact of histology on efficacy of pemetrexed: pemetrexed in second-line setting and as maintenance therapy after first-line treatment in Chinese patients with advanced NSCLC
Yilong Wu ... Yan Sun
Chinese journal of oncology | VOL. 36
Yilong Wu, et. al.Yilong Wu ... Yan Sun
01 Jan 2014
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
What’s in a name? Memory NK cells for cancer immunotherapy
Sean J Judge ... Robert J Canter
Journal for ImmunoTherapy of Cancer | VOL. 13
Sean J Judge, et. al.Sean J Judge ... Robert J Canter
31 Jan 2025
Arginase-1-specific T cells target and modulate tumor-associated macrophages
Evelina Martinenaite ... Mads Hald Andersen
Journal for ImmunoTherapy of Cancer | VOL. 13
Evelina Martinenaite, et. al.Evelina Martinenaite ... Mads Hald Andersen
29 Jan 2025
Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma
Binod Dhakal ... Daniel H Fowler
Journal for ImmunoTherapy of Cancer | VOL. 13
Binod Dhakal, et. al.Binod Dhakal ... Daniel H Fowler
28 Jan 2025
Plasma membrane-coated nanoparticles and membrane vesicles to orchestrate multimodal antitumor immunity
Yusuke Ito ... Yuki Kagoya
Journal for ImmunoTherapy of Cancer | VOL. 13
Yusuke Ito, et. al.Yusuke Ito ... Yuki Kagoya
26 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.